Prenetics Global Net Income Over Time
| PRE Stock | USD 20.96 0.44 2.06% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Prenetics Global Performance and Prenetics Global Correlation. Prenetics | Build AI portfolio with Prenetics Stock |
Will Reinsurance sector continue expanding? Could Prenetics diversify its offerings? Factors like these will boost the valuation of Prenetics Global. Anticipated expansion of Prenetics directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Prenetics Global data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (3.59) | Revenue Per Share | Quarterly Revenue Growth 2.028 | Return On Assets | Return On Equity |
Understanding Prenetics Global requires distinguishing between market price and book value, where the latter reflects Prenetics's accounting equity. The concept of intrinsic value - what Prenetics Global's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Prenetics Global's price substantially above or below its fundamental value.
It's important to distinguish between Prenetics Global's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Prenetics Global should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Prenetics Global's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Net Income Analysis
Compare Prenetics Global and related stocks such as Neuronetics, Atlantic International, and MaxCyte Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STIM | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (11.2 M) | (16.1 M) | (24.1 M) | (29 M) | (27.5 M) | (31.2 M) | (37.2 M) | (30.2 M) | (43.7 M) | (39.3 M) | (41.3 M) |
| ATLN | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.4 M) | (1.7 M) | (2.9 M) | (2.5 M) | (1 M) | (40.8 M) | (3.2 M) | (15.3 M) | (135.5 M) | (121.9 M) | (115.8 M) |
| MXCT | (2 M) | (2 M) | (2 M) | (958.2 K) | (1.8 M) | (1.4 M) | (3.3 M) | (9.9 M) | (8.9 M) | (12.9 M) | (11.8 M) | (19.1 M) | (23.6 M) | (37.9 M) | (41.1 M) | (36.9 M) | (35.1 M) |
| TLSI | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (28.8 M) | (47.2 M) | (59.4 M) | (33.2 M) | (29.9 M) | (31.4 M) |
| PROF | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (8.2 M) | (11.8 M) | (12.1 M) | (15 M) | (15.2 M) | (15.2 M) | (21.6 M) | (30.7 M) | (28.7 M) | (28.6 M) | (26.5 M) | (23.8 M) | (25 M) |
| OSUR | (2.6 M) | (8.8 M) | (15.1 M) | (11.2 M) | (4.6 M) | 8.2 M | 19.7 M | 30.9 M | 20.4 M | 16.7 M | (14.9 M) | (23 M) | (17.1 M) | 53.7 M | (19.5 M) | (22.4 M) | (21.3 M) |
| IMDX | (3.5 M) | (3.5 M) | (3.5 M) | (3.5 M) | (5 M) | (8.7 M) | (11.2 M) | (19.4 M) | (15.8 M) | (22.3 M) | (29.9 M) | (64.1 M) | (72.9 M) | (27.8 M) | (60.7 M) | (54.6 M) | (51.9 M) |
| ARMP | (5.1 M) | (3.8 M) | (1.1 M) | (64.6 M) | 23.1 M | (516 K) | (18.8 M) | (12.8 M) | (12.1 M) | (19.5 M) | (22.2 M) | (23.2 M) | (36.9 M) | (69 M) | (18.9 M) | (17 M) | (17.9 M) |
| SGMO | (308 K) | (35.8 M) | (22.3 M) | (26.6 M) | (26.4 M) | (40.7 M) | (71.7 M) | (54.6 M) | (68.3 M) | (75.8 M) | (121.1 M) | (178.3 M) | (192.3 M) | (257.8 M) | (97.9 M) | (88.1 M) | (83.7 M) |
| CDXS | (18.7 M) | (16.6 M) | (30.9 M) | (41.3 M) | (19.1 M) | (7.6 M) | (8.6 M) | (23 M) | (10.9 M) | (11.9 M) | (24 M) | (21.3 M) | (33.6 M) | (76.2 M) | (65.3 M) | (58.7 M) | (55.8 M) |
Prenetics Global and related stocks such as Neuronetics, Atlantic International, and MaxCyte Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Prenetics Global financial statement analysis. It represents the amount of money remaining after all of Prenetics Global operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Prenetics Global | PRE |
Specialization | Financials, Diagnostics & Research |
| Business Address | Unit 703-706, K11 |
| Exchange | NASDAQ Exchange |
USD 20.96
Check out Prenetics Global Performance and Prenetics Global Correlation. For information on how to trade Prenetics Stock refer to our How to Trade Prenetics Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Prenetics Global technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.